| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/28/2004 | CN1492875A TTK in diagnosis and as a therapeutic target in cancer |
| 04/28/2004 | CN1492767A Modified anti-EGFR antibody with reduced immunogenicity |
| 04/28/2004 | CN1492040A Natural antibody of monoclonal human |
| 04/28/2004 | CN1491723A Medicine for treating hypersensitive disease and its preparing method |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/28/2004 | CN1147316C Process for preparing influenza virus vaccine by static hydraulic inactivation |
| 04/27/2004 | US6727350 Toso |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727093 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by cd8+ class i major histocompatibility complex restricted cytotoxic t-lymphocytes of patients harboring latent human cytomegalovirus infection |
| 04/27/2004 | US6727078 Genetic engineering; removal, insertion gene; lentivirus |
| 04/27/2004 | US6726912 Papillomavirus polyprotein constructs |
| 04/27/2004 | US6726910 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/27/2004 | US6726895 Tumor radiotherapy |
| 04/27/2004 | US6726860 Production scale method of forming microparticles |
| 04/27/2004 | CA2296244C Adjuvants for use in vaccines |
| 04/27/2004 | CA2058370C Monoclonal antibodies against human tumor necrosis factor .alpha. |
| 04/25/2004 | CA2446662A1 Plasmodium falciparum virulence factor var o |
| 04/25/2004 | CA2409897A1 Plasmodium falciparum virulence factor var o |
| 04/22/2004 | WO2004033723A2 Neurodegenerative disease-associated gene |
| 04/22/2004 | WO2004033705A2 Viral interferon antagonists and uses therefor |
| 04/22/2004 | WO2004033690A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | WO2004033677A2 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 04/22/2004 | WO2004033663A2 Carbohydrate-based synthetic vaccines for hiv |
| 04/22/2004 | WO2004033500A1 Peptides modulating caspase activation |
| 04/22/2004 | WO2004033483A2 Liposomal system and method of using same |
| 04/22/2004 | WO2004032962A1 Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents |
| 04/22/2004 | WO2004032961A1 Bispecific anti-erb-b antibodies and their use in tumor therapy |
| 04/22/2004 | WO2004032960A1 Pharmaceutical compositions directed to erb-b1 receptors |
| 04/22/2004 | WO2004032959A2 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 04/22/2004 | WO2004032958A1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 04/22/2004 | WO2004032957A1 Immunization of non-human mammals against streptococcus equi |
| 04/22/2004 | WO2004032956A1 Vaccine composition comprising interleukin-15 (il-15) |
| 04/22/2004 | WO2004032880A2 Method for inhibiting angiogenesis with ship-1 inhibitors |
| 04/22/2004 | WO2004032874A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 04/22/2004 | WO2004032870A2 Methods for treating post-surgical pain by admisnistering a nerve growth factor antagonist and compositions containing the same |
| 04/22/2004 | WO2004032868A2 Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 04/22/2004 | WO2004032865A2 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 04/22/2004 | WO2004032860A2 Hiv vaccine formulations |
| 04/22/2004 | WO2004032857A2 Antibody therapy |
| 04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/22/2004 | WO2004032832A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 04/22/2004 | WO2004032829A2 Immunostimulatory compositions and methods of stimulating an immune response |
| 04/22/2004 | WO2004032828A2 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| 04/22/2004 | WO2004032622A2 Production of peptides in plants as viral coat protein fusions |
| 04/22/2004 | WO2004032599A2 Novel immunogenic proteins of leptospira |
| 04/22/2004 | WO2004022657A8 Increasing of the resorption of substances via skin and mucous membranes |
| 04/22/2004 | WO2004015099A3 Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| 04/22/2004 | WO2003103571A3 Flavivirus vaccines |
| 04/22/2004 | WO2003086286A3 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
| 04/22/2004 | WO2003051272A9 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 04/22/2004 | WO2003048198A3 Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof |
| 04/22/2004 | WO2003046506A3 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies |
| 04/22/2004 | WO2003043587A3 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 04/22/2004 | WO2003040345A3 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
| 04/22/2004 | WO2003020893A3 New adenovirus type 7 vectors |
| 04/22/2004 | WO2002100148A3 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 04/22/2004 | WO2002098362A3 Use of rank antagonists to treat cancer |
| 04/22/2004 | WO2002094852A8 Taci-immunoglobulin fusion proteins |
| 04/22/2004 | WO2002092782A3 Diagnosis and treatment of malignant neoplasms |
| 04/22/2004 | WO2002092017A8 Human antipneumococcal antibodies from non-human animals |
| 04/22/2004 | WO2002090567A3 Sperm-specific cation channel, and uses therefor |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | WO1991007986A8 Method of treating septic shock |
| 04/22/2004 | US20040078837 Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12 |
| 04/22/2004 | US20040077847 Nucleic acid encoding a pneumoccocal surface protein c gene or epitope |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077840 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroups B epitopes |
| 04/22/2004 | US20040077601 Methods and compositions relating to isoleucine boroproline compounds |
| 04/22/2004 | US20040077577 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes |
| 04/22/2004 | US20040077552 Inflammation-inhibiting compounds |
| 04/22/2004 | US20040077548 NY-ESO-1 peptide derivatives, and uses thereof |
| 04/22/2004 | US20040077540 Permeabilizing peptide; reversibly enhancing paracellular transport; inhibits homotypic binding |
| 04/22/2004 | US20040077534 Methods and compositions for the treatment and prevention of Staphylococcus a ureus infections |
| 04/22/2004 | US20040077532 Aglyco products and methods of use |
| 04/22/2004 | US20040077086 Animal protein free media for cultivation of cells |
| 04/22/2004 | US20040077067 Therapeutic and prophylactic agents derived from aeromonas hydrophila bacterial surface proteins |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040077007 Human SMN-like protein |
| 04/22/2004 | US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection, |
| 04/22/2004 | US20040076980 Method of separating extra-chromosonal dna from other cellular components |
| 04/22/2004 | US20040076976 Aopb gene, protein,homologs, fragments and variants thereof, and their use for cell surface display |
| 04/22/2004 | US20040076955 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/22/2004 | US20040076646 Stimulating the immune system of a host to mount an attack on tumor cells and/or antigens |
| 04/22/2004 | US20040076645 Ghrelin-carrier conjugates |
| 04/22/2004 | US20040076644 Immunogenic preparation that is recognized as a specific monoclonal antibody and a veterinarily acceptable vehicle or excipient |
| 04/22/2004 | US20040076643 HIV-encoded chemoattractant |
| 04/22/2004 | US20040076642 Equine abortion virus |
| 04/22/2004 | US20040076640 Incubating first means expressing the target receptor of an infectious pathogen, with a second means expressing a region regconizing the targets, to form a complex and contacting with a binding agent at different intervals |
| 04/22/2004 | US20040076639 Antiallergens is encoded from Mycobacterium, genetic vaccines, for immunotherapy treating atopic dermatitis, asthma, rhinitis, or conjunctivitis, as immunosuppressants inhibiting the production of interleukin-4 |
| 04/22/2004 | US20040076638 Methods for preparing bacillus anthracis protective antigen for use in vaccines |
| 04/22/2004 | US20040076636 HIV immunogenic complexes |
| 04/22/2004 | US20040076635 Genetic vaccine, polypeptide encoded by a nucleotide sequence genome, a vector, a transgenic cell, for preventing and treating viral infections |
| 04/22/2004 | US20040076634 An envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 04/22/2004 | US20040076633 Genetic vaccines comprising a 1H-imidazo(4,5-c)- 4-amine derivative as an adjuvant, for increasing immune responses in a mammal to the encoded antigen |
| 04/22/2004 | US20040076632 DNA vaccine against feline immunodeficiency virus |